Eli Lilly (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 square feet of 2300 Market, a life sciences facility in Center City newly developed and operated by Breakthrough Properties. Biotechs based in the site will have access to dedicated, fully equipped wet lab facilities alongside strategic scientific engagement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- LifeMD price target lowered to $8 from $12 at KeyBanc
- Eli Lilly price target raised to $1,150 from $1,050 at JPMorgan
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk Cuts Weight-Loss Drug Prices
- Novo launches introductory self-pay offer for Wegovy, Ozempic for $199 per month